$3.95
-0.02-0.5%
Last update: Nov 5, 4:51 PM
Clene Inc (CLNN) Stock Price, Quote, News & History
CLNNNASDAQ
FDA signals accelerated pathway for Clene's ALS drug CNM-Au8, with NDA filing planned and mixed technical indicators in focus.
You can purchase shares of Clene (NASDAQ:CLNN) through any online brokerage.
Other companies in Clene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Clene has a consensus price target of $31.29.
The stock price for Clene (NASDAQ: CLNN) is $4.04 last updated November 5, 2026 at 4:51 PM EST.
There are no upcoming dividends for Clene.
Clene does not have any upcoming earnings scheduled.
There is no upcoming split for Clene.
Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative...
